Pramipexole to Enhance Social Connections (NCT06269146)
Targeting Dopamine-Mediated Social Reward Sensitivity to Remediate Social Disconnection
🩺 Plain-English Summary (8th-Grade Level)
This study seeks to understand if the medication pramipexole improves social connectedness and functioning in adults (ages 18-50) who experience anxiety or depression. The study plans to enroll 108 participants total across two sites (University of California San Diego and New York State Psychiatric Institute). Pramipexole will be given in a 6-week randomized, double-blind, placebo-controlled trial. Social reward processing will be assessed using measures of brain function (fMRI), behavior, and self-report at baseline and week 6. Knowledge gained from this study will help determine the therapeutic potential of targeting the dopamine system to remediate social disconnection as an anxiety and depression intervention.
Who can join: Review the eligibility criteria below.
Location: University of California, San Diego — San Diego, California
Age range: 18 Years to 50 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- University of California, San Diego — San Diego, California
- New York State Psychiatric Institute — New York, New York
📞 Contact the Study Coordinator
Phone: (858) 534-6436
Email: nbeg@health.ucsd.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Anxiety Disorders
- Fluoxetine vs CBT in Childhood Anxiety Disorders — Los Angeles, California
- Pre-Post Intervention Study to Investigate the Safety, Feasibility, & Efficacy of the NeurGear ZenBud System for the Treatment of Anxiety & Anxiety-Related Symptoms — Rochester, New York
- Digital Coach to Support Exposure Therapy Homework for Anxious Youth — Belmont, Massachusetts
- MOCHA: Embedded Inpatient Mental Health Care for High-Risk Perinatal Patients — Indianapolis, Indiana
- Connectomic Targeted TMS Target for Refractory Anxiety — Boston, Massachusetts
- Initial Assessment of the Feasibility and Efficacy of a Scalable Digital CBT for Generalized Anxiety and Associated Health Behaviors in a Cardiovascular Disease Population — Boston, Massachusetts
Explore by condition: All Anxiety Disorders clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.